$5.4bn deal

Pfizer to buy Global Blood Therapeutics in $5.4bn cash deal

United States pharmaceutical maker, Pfizer, and biopharmaceutical company, Global Blood Therapeutics (GBT), on Monday, agreed that Pfizer would acquire GBT…

2 years ago

This website uses cookies.